BMC Cancer

official impact factor 3.15

Open Access Highly Access Technical advance

Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material

Simon A Joosse1, Erik H van Beers1 and Petra M Nederlof2*

Author Affiliations

1 Division of Experimental Therapy, the Netherlands Cancer Institute, Amsterdam, The Netherlands

2 Department of Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands

For all author emails, please log on.

BMC Cancer 2007, 7:43 doi:10.1186/1471-2407-7-43

Published: 7 March 2007

Abstract

Background

Array Comparative Genomic Hybridization (aCGH) is a rapidly evolving technology that still lacks complete standardization. Yet, it is of great importance to obtain robust and reproducible data to enable meaningful multiple hybridization comparisons. Special difficulties arise when aCGH is performed on archival formalin-fixed, paraffin-embedded (FFPE) tissue due to its variable DNA quality. Recently, we have developed an effective DNA quality test that predicts suitability of archival samples for BAC aCGH.

Methods

In this report, we first used DNA from a cancer cell-line (SKBR3) to optimize the aCGH protocol for automated hybridization, and subsequently optimized and validated the procedure for FFPE breast cancer samples. We aimed for highest throughput, accuracy, and reproducibility applicable to FFPE samples, which can also be important in future diagnostic use.

Results

Our protocol of automated array-CGH on archival FFPE ULS-labeled DNA showed very similar results compared with published data and our previous manual hybridization method.

Conclusion

This report combines automated aCGH on unamplified archival FFPE DNA using non-enzymatic ULS labeling, and describes an optimized protocol for this combination resulting in improved quality and reproducibility.